vs
Side-by-side financial comparison of Cherry Hill Mortgage Investment Corp (CHMI) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $11.8M, roughly 1.6× Cherry Hill Mortgage Investment Corp). On growth, ROCKWELL MEDICAL, INC. posted the faster year-over-year revenue change (-25.6% vs -37.2%). Over the past eight quarters, ROCKWELL MEDICAL, INC.'s revenue compounded faster (-10.1% CAGR vs -15.2%).
Cherry Hill Mortgage Investment Corp is a U.S.-headquartered real estate finance firm focused on acquiring, investing in and managing residential mortgage-related assets. Its core holdings include agency mortgage-backed securities, residential loans and mortgage servicing rights, operating primarily in the U.S. domestic housing finance market.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
CHMI vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.8M | $18.3M |
| Net Profit | — | $-554.0K |
| Gross Margin | 78.9% | 21.1% |
| Operating Margin | 72.1% | -2.2% |
| Net Margin | — | -3.0% |
| Revenue YoY | -37.2% | -25.6% |
| Net Profit YoY | — | 26.7% |
| EPS (diluted) | $0.18 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.8M | $18.3M | ||
| Q3 25 | $8.6M | $15.9M | ||
| Q2 25 | $6.0M | $16.1M | ||
| Q1 25 | $-3.0M | $18.9M | ||
| Q4 24 | $18.7M | $24.7M | ||
| Q3 24 | $-7.1M | $28.3M | ||
| Q2 24 | $6.6M | $25.8M | ||
| Q1 24 | $16.3M | $22.7M |
| Q4 25 | — | $-554.0K | ||
| Q3 25 | $4.5M | $-1.8M | ||
| Q2 25 | $1.6M | $-1.5M | ||
| Q1 25 | $-7.0M | $-1.5M | ||
| Q4 24 | — | $-756.0K | ||
| Q3 24 | $-12.4M | $1.7M | ||
| Q2 24 | $784.0K | $343.0K | ||
| Q1 24 | $12.1M | $-1.7M |
| Q4 25 | 78.9% | 21.1% | ||
| Q3 25 | 73.2% | 14.3% | ||
| Q2 25 | 67.7% | 15.6% | ||
| Q1 25 | 183.4% | 16.1% | ||
| Q4 24 | 83.3% | 14.7% | ||
| Q3 24 | 145.3% | 22.0% | ||
| Q2 24 | 47.5% | 17.6% | ||
| Q1 24 | 83.9% | 13.5% |
| Q4 25 | 72.1% | -2.2% | ||
| Q3 25 | 56.0% | -9.9% | ||
| Q2 25 | 44.4% | -8.4% | ||
| Q1 25 | 223.6% | -7.2% | ||
| Q4 24 | 76.2% | -2.1% | ||
| Q3 24 | 171.8% | 6.8% | ||
| Q2 24 | 22.0% | 2.0% | ||
| Q1 24 | 78.0% | -5.8% |
| Q4 25 | — | -3.0% | ||
| Q3 25 | 52.7% | -11.0% | ||
| Q2 25 | 25.9% | -9.3% | ||
| Q1 25 | 229.2% | -8.0% | ||
| Q4 24 | — | -3.1% | ||
| Q3 24 | 175.8% | 5.9% | ||
| Q2 24 | 11.9% | 1.3% | ||
| Q1 24 | 73.7% | -7.6% |
| Q4 25 | $0.18 | $-0.01 | ||
| Q3 25 | $0.05 | $-0.05 | ||
| Q2 25 | $-0.03 | $-0.05 | ||
| Q1 25 | $-0.29 | $-0.04 | ||
| Q4 24 | $0.30 | $-0.02 | ||
| Q3 24 | $-0.49 | $0.04 | ||
| Q2 24 | $-0.06 | $0.01 | ||
| Q1 24 | $0.32 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $54.9M | $10.7M |
| Total DebtLower is stronger | $146.3M | — |
| Stockholders' EquityBook value | $236.0M | $37.0M |
| Total Assets | $1.5B | $57.1M |
| Debt / EquityLower = less leverage | 0.62× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $54.9M | $10.7M | ||
| Q3 25 | $55.4M | $13.6M | ||
| Q2 25 | $58.0M | $12.5M | ||
| Q1 25 | $47.3M | $11.4M | ||
| Q4 24 | $46.3M | $15.7M | ||
| Q3 24 | $50.2M | $12.3M | ||
| Q2 24 | $52.4M | $11.9M | ||
| Q1 24 | $47.5M | $6.6M |
| Q4 25 | $146.3M | — | ||
| Q3 25 | $148.0M | — | ||
| Q2 25 | $150.1M | — | ||
| Q1 25 | $150.1M | — | ||
| Q4 24 | $152.1M | — | ||
| Q3 24 | $151.8M | — | ||
| Q2 24 | $160.5M | — | ||
| Q1 24 | $167.5M | — |
| Q4 25 | $236.0M | $37.0M | ||
| Q3 25 | $233.1M | $37.0M | ||
| Q2 25 | $229.9M | $30.4M | ||
| Q1 25 | $226.6M | $31.5M | ||
| Q4 24 | $230.3M | $32.6M | ||
| Q3 24 | $236.7M | $29.1M | ||
| Q2 24 | $234.5M | $23.5M | ||
| Q1 24 | $247.0M | $20.6M |
| Q4 25 | $1.5B | $57.1M | ||
| Q3 25 | $1.5B | $57.5M | ||
| Q2 25 | $1.5B | $52.6M | ||
| Q1 25 | $1.4B | $54.0M | ||
| Q4 24 | $1.5B | $59.2M | ||
| Q3 24 | $1.6B | $57.1M | ||
| Q2 24 | $1.4B | $53.0M | ||
| Q1 24 | $1.4B | $50.7M |
| Q4 25 | 0.62× | — | ||
| Q3 25 | 0.63× | — | ||
| Q2 25 | 0.65× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.66× | — | ||
| Q3 24 | 0.64× | — | ||
| Q2 24 | 0.68× | — | ||
| Q1 24 | 0.68× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $19.1M | $2.3M |
| Free Cash FlowOCF − Capex | — | $2.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.1M | $2.3M | ||
| Q3 25 | $-2.4M | $-1.3M | ||
| Q2 25 | $12.5M | $1.8M | ||
| Q1 25 | $682.0K | $-3.5M | ||
| Q4 24 | $-4.7M | $865.0K | ||
| Q3 24 | $4.4M | $4.3M | ||
| Q2 24 | $4.1M | $1.4M | ||
| Q1 24 | $-19.1M | $-2.4M |
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | -0.53× | — | ||
| Q2 25 | 7.98× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | 5.18× | 4.20× | ||
| Q1 24 | -1.58× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CHMI
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
